1Trimbos JB,Vergote I,Bolis G,et al.Impact of adjuvant chemotherapy and surgical staging in early- stage ovarian carcinoma:European organisation for research and treatment of cancer -adjuvant chemo therapy in ovarian neoplasm trial [J].JNatl Cancer Inst ,2003,95 (2):113.
2Dinniwell R,Lock M,Pintilie M,et al.Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer [J].Int J Radiat Oncol Biol Phys ,2005,62( 1 ):104.
3Waters J,Chau I,Norman AR,et al.Gemcitabine (GEM),cisplatin (P) and methylprednisolone:a salvage regimen in relapsed hodgkin's disease and non- hodgkin's lymphoma[J].ASCO,2004,abs:6 589.
4Cooper BW,Veal GJ,Radivoyevitch T,et al.A phase Ⅰ and pharmacodynamic study of fludarabine,carboplatin,and topotecan in patients with relapsed,refractory,or high - risk acute leukemia[J].Clin Cancer Res ,2004,10(20) :6 830.
5Duenas Gonzalez A,Cetina Perez L,Lopez Graniel C,et al.Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer:a randomized phase Ⅱ study[J].Int J Radiat Oncol Biol Phys ,2005,61 (3):817.
6Kato H,Fukuchi M,Manda R,et al.The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas [J] .Anticancer Res,2004,24(6) :4 091.
